About Ossio
Ossio is a company based in Caesarea (Israel) founded in 2014 by Orahn Preiss Bloom.. Ossio has raised $89.01 million across 4 funding rounds from investors including MVM Partners, Questa Capital and OCV Partners. Ossio offers products and services including Suture Anchors, Compression Staple, Compression Screws, Trimmable Fixation Nails, and Threaded Trimmable Fixation Nails. Ossio operates in a competitive market with competitors including Biocomposites, CartiHeal, Theradaptive, MiMedx Group and RevBio, among others.
- Headquarter Caesarea, Israel
- Founders Orahn Preiss Bloom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ossio Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$89.01 M (USD)
in 4 rounds
-
Latest Funding Round
$27.6 M (USD), Series C
Dec 02, 2024
-
Investors
MVM Partners
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ossio
Ossio offers a comprehensive portfolio of products and services, including Suture Anchors, Compression Staple, Compression Screws, Trimmable Fixation Nails, and Threaded Trimmable Fixation Nails. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Devices for securing sutures in bone fixation procedures.
Tool for compressing bones to aid healing processes.
Screws used for stabilizing fractures during recovery.
Nails that provide adjustable support for bone alignment.
Threaded nails for enhanced fixation in orthopedic repairs.
System for correcting and fixing hammertoe deformities.
Unlock access to complete
Funding Insights of Ossio
Ossio has successfully raised a total of $89.01M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $27.6 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $27.6M
-
First Round
First Round
(03 Jan 2018)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series C - Ossio | Valuation | Questa Capital | |
| Oct, 2022 | Amount | Series C - Ossio | Valuation | MVM |
|
| Mar, 2019 | Amount | Series A - Ossio | Valuation | OCV Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ossio
Ossio has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include MVM Partners, Questa Capital and OCV Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage VC and PE investments are directed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Private equity investments in healthcare companies are managed.
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided by OCV Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ossio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ossio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ossio Comparisons
Competitors of Ossio
Ossio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocomposites, CartiHeal, Theradaptive, MiMedx Group and RevBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| domain | founded_year | HQ Location |
Implants for bone and cartilage regeneration are developed and provided.
|
|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ossio
Frequently Asked Questions about Ossio
When was Ossio founded?
Ossio was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is Ossio located?
Ossio is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
Who is the current CEO of Ossio?
Brian Verrier is the current CEO of Ossio.
Is Ossio a funded company?
Ossio is a funded company, having raised a total of $89.01M across 4 funding rounds to date. The company's 1st funding round was a Series A of $22M, raised on Jan 03, 2018.
What does Ossio do?
Ossio was founded in 2014 in Caesarea, Israel, within the biotechnology sector focused on orthopedics. Operations center on the development of OSSIOfiber, a biocomposite platform integrating synthetic bone fibers for mechanical reinforcement with bioabsorbable polymer resin for binding and bone growth promotion. This technology supports fixation devices that gradually resorb, aiding natural bone regeneration in clinical applications.
Who are the top competitors of Ossio?
Ossio's top competitors include EpiBone, Theradaptive and MiMedx Group.
What products or services does Ossio offer?
Ossio offers Suture Anchors, Compression Staple, Compression Screws, Trimmable Fixation Nails, and 2 more products and services.
Who are Ossio's investors?
Ossio has 6 investors. Key investors include MVM Partners, Questa Capital, OCV Partners, Courage Capital Management, and OrthoVision.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.